Dr. Jennifer Lanay Balentine, MD

Dr. Balentine practices at Northwest Eye Associates in Portland, Oregon.

Dr. Balentine's NPI, 1962482638, was assigned on January 19, 2006. Dr. Balentine graduated from University of Colorado Anschutz Medical Campus in 1998. Dr. Balentine's Oregon license number on file is MD24311.

Dr. Balentine's primary practice is Northwest Eye Associates, at 2222 Nw Lovejoy St, Portland, OR 97210-3033. The practice phone is (503) 227-6568.

Dr. Balentine's primary practice is Northwest Eye Associates in Portland, Oregon. Dr. Balentine is also affiliated with Providence St. Vincent Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balentine practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Balentine's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Balentine is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Balentine's licenses on file in 2 states: Oregon and Colorado.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Balentine treats.

CMS data shows 2,050 Medicare services from Dr. Balentine across 12 procedure codes in 2024, for 621 Medicare patients. Medicare paid $126,728 for them.

CMS counts 621 Medicare patients who saw Dr. Balentine in 2024. The largest group is 75 to 84, with 285 patients. 66% of them have high cholesterol, and 59% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Balentine's median patient age at 76, with 60% women.

In 2024, Dr. Balentine wrote 1,097 Medicare Part D claims for 277 patients. 52% of them were for generic drugs. CMS names the drug for 978 of them, across 18 drugs with 11 or more claims each, at $162,232 in total drug cost. In 2023, CMS named 1,015 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Balentine for performance year 2024, reported individually. Dr. Balentine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 95 procedures of cataract surgery by Dr. Balentine, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Balentine. Dr. Balentine's most frequent co-author is Vikram Durairaj, MD.

CMS Open Payments shows 52 general payments to Dr. Balentine from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Alcon Laboratories Inc paid the most, $309.

Dmand AI lists 2 awards for Dr. Balentine, most recently CMS Stage 1 EHR in 2013.

Dr. Balentine graduated from University of Colorado Anschutz Medical Campus in 1998. Dr. Balentine is a member of AAO.

Dr. Balentine is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.